Compare NKTX & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | IMMR |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 215.8M |
| IPO Year | 2020 | 1999 |
| Metric | NKTX | IMMR |
|---|---|---|
| Price | $2.95 | $7.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $11.33 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 548.9K | 326.5K |
| Earning Date | 05-11-2026 | 04-13-2026 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ 11.88 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $35,013,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $51.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $5.25 |
| 52 Week High | $3.72 | $8.05 |
| Indicator | NKTX | IMMR |
|---|---|---|
| Relative Strength Index (RSI) | 56.10 | 40.52 |
| Support Level | $2.59 | $6.30 |
| Resistance Level | $3.29 | $7.82 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 39.13 | 7.41 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.